NCT00807495 · Interventional trial
Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma
Overall registry status Completed
Phase 2
Conditions Burkitt's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, T-cell Lymphoma, Excluding Primary Cutaneous T-cell Lymphoma, Transformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component
Delaware Valley sites
- Hematology Oncology Associates, Virtua Memorial Hospital Burlington County · Mount Holly, NJ · Burlington County
First posted
Registry updated
Added to the directory